Biotelemetry Inc (BEAT)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

227 WASHINGTON STREET SUITE 210 CONSHOHOCKEN, PA 19428

CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health. It offers CardioNet System, which incorporates a patient-worn sensor attached to electrodes that capture two-lead electrocardiogram (ECG) data and communicates wirelessly with a compact monitor that analyzes incoming information by applying proprietary algorithms designed to detect arrhythmias and eliminate data noise. Its CardioNet System automatically transmits the ECG data to the CardioNet Monitoring Center, when the monitor detects an arrhythmic event. The company also offers Holter monitoring services that store an image of the electrical impulses of every heartbeat or irregularity in either digital format on an internal compact flashcard or in analog format on a standard cassette tape located inside the monitor; and event monitoring services to record and store approximately 540 seconds of ECG signal, as well as pacemaker monitoring services. It markets its arrhythmia monitoring solutions, including the CardioNet System, primarily to cardiologists and electrophysiologists.

Data based on most recent fiscal year report
Market Cap1.016 Billion Shares Outstanding32.41 Million Avg Volume741.118 Thousand
1-Yr BETA vs S&P TR1.689 Current Ratio1.77 Quick Ratio1.66
View SEC Filings from BEAT instead.
Q2 2019 All Institutions Hedge Funds 1
To trade BEAT now:
Filers who had this stock in their top 10: 2 1 (0.1%)
13F Filers holding this stock: 246 27 (2.79%)
Aggregate 13F shares on 06/30/2019: 30.687 Million 4.804 Million
Aggregate 13F shares on 03/31/2019: 30.662 Million 2.342 Million
Percent change: 0.08% 105.13%
Funds creating new positions: 34 6
Funds Adding to an existing position: 108 14
Funds closing out their position: 87 14
Funds reducing their position: 72 6
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding BEAT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

44.3 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

40 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

THURMAN RANDY H

  • Director
0 2019-10-03 0

RUBIN ROBERT J.

  • Director
0 2019-09-06 2

FEROLA PETER SVP & GENERAL COUNSEL

  • Officer
8,507 2019-09-04 3

GALVAN MARTIN P FORMER VP OF FINANCE & CFO

  • Officer
102,409 2019-08-30 0

MIDDLETON FRED A

  • Director
0 2019-06-20 0

CONTI ANTHONY JAMES

  • Director
15,628 2019-06-20 1

GORMAN KIRK E

  • Director
176,392 2019-05-03 3

RIMEL REBECCA W

  • Director
113,436 2019-05-03 1

FRICK JOSEPH A.

  • Director
57,462 2019-05-03 1

HILL COLIN

  • Director
18,810 2019-05-03 1

RIETIKER STEPHEN

  • Director
78,701 2019-05-03 3

OLSON TIFFANY

  • Director
3,007 2019-05-03 2

DIETCH LAURA

  • Director
2,424 2019-05-03 2

GETZ HEATHER C EXECUTIVE VP & CFO

  • Officer
78,879 2019-02-14 4

CAPPER JOSEPH H PRESIDENT & CEO

  • Officer
  • Director
162,442 2019-02-14 2

WISNIEWSKI DANIEL SVP, TECHNICAL OPERATIONS

  • Officer
24,149 2019-02-14 1

BROADWAY FRED PRESIDENT BIOTEL HEART

  • Officer
22,904 2019-02-14 1

MYERS WOODROW A JR

  • Director
0 2018-12-20 0

MARGOLIES MATTHEW PRESIDENT

  • Officer
No longer subject to file 2017-12-28 0

HRENKO GEORGE SVP - HUMAN RESOURCES

  • Officer
20,518 2017-02-27 0

PRYSTOWSKY ERIC N

  • Director
52,593 2016-05-24 0

REIN HARRY T

  • Director
No longer subject to file 2016-03-14 0

GELDART MICHAEL SENIOR VICE PRESIDENT

  • Officer
65,396 2015-06-17 0

AHRENS RONALD A

  • Director
196,670 2015-04-30 0

MCNAMARA ANNA SENIOR VICE PRES/CLINICAL OP.

  • Officer
90,903 2013-02-19 0

GROPPER CHARLES SENIOR VICE PRESIDENT

  • Officer
51,422 2012-02-21 0

SCHULER ANTHONY SENIOR VICE PRESIDENT

  • Officer
25,121 2012-02-21 0

KASRAWI JAREER SENIOR VICE PRESIDENT

  • Officer
26,075 2012-02-21 0

LEONE PHILIP SENIOR VICE PRESIDENT

  • Officer
43,655 2011-03-04 0

IMPERATO JOHN F SENIOR VICE PRESIDENT

  • Officer
39,179 2010-05-10 0

SWEENEY JAMES M

  • Director
635,966 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT V

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

SANDERLING V BETEILIGUNGS GMBH & CO KG

SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

SANDERLING V LTD PARTNERSHIP

  • 10% Owner
944,366 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT IV

SANDERLING (FERI TRUST) VENTURE PARTNERS IV, L.P.

SANDERLING IV LIMITED PARTNERSHIP

SANDERLING IV BIOMEDICAL CO INVESTMENT FUND L P

SANDERLING IV BIOMEDICAL L P

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

  • 10% Owner
631,829 2008-08-06 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING V BETEILIGUNGS GMBH & CO KG

SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP

SANDERLING VENTURE PARTNERS V CO INVESTMENT FUND, LP

SANDERLING V LTD PARTNERSHIP

  • 10% Owner
716,018 2008-03-25 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING VENTURES MANAGEMENT IV

SANDERLING VENTURES MANAGEMENT V

SANDERLING VENTURES MANAGEMENT VI

SANDERLING VI LIMITED PARTNERSHIP

SANDERLING VENTURE PARTNERS VI CO INVESTMENT FUND LP

SANDERLING VI BETEILIGUNGS GMBH & CO KG

  • 10% Owner
357,461 2008-03-25 0

SANDERLING VENTURE PARTNERS IV, L.P.

SANDERLING IV LIMITED PARTNERSHIP

SANDERLING (FERI TRUST) VENTURE PARTNERS IV, L.P.

SANDERLING IV BIOMEDICAL CO INVESTMENT FUND L P

SANDERLING IV BIOMEDICAL L P

SANDERLING VENTURE PARTNERS IV CO INVESTMENT FUND LP

  • 10% Owner
1,484,576 2008-03-25 0

GUIDANT INVESTMENT CORP

  • 10% Owner
No longer subject to file 2008-03-25 0

COHEN ARIE PRESIDENT AND CEO

  • Officer
  • Director
0 2008-03-18 0

GEROLAMO EMMANUEL SENIOR VP SALES & MARKETING

  • Officer
0 2008-03-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 6,835 $8.68 a 19,622 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 10,293 d 3,433 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 S 44,276 $39.03 d 8,507 8,507.00 direct yes

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 10,293 $9.57 a 47,666 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 1,853 d 5,561 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 17,751 d 0 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 1,853 $33.35 a 52,783 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 17,751 $10.36 a 37,373 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 3,264 d 3,265 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 6,835 d 0 8,507.00 direct

FEROLA PETER - Officer SVP & GENERAL COUNSEL

2019-09-04 M 3,264 $24.65 a 50,930 8,507.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments